Thursday, August 27th Edition

Presented by

 

Today’s Big Story

Meta’s $17.1 Billion Settlement

 

The landmark judgement forces the social media giant to pay up and make major changes

 

Meta settled the biggest child-safety case in tech history Wednesday, cutting a deal with a bipartisan coalition of state attorneys general just five days after opening arguments in a federal jury trial in Oakland, California. U.S. District Judge Yvonne Gonzalez Rogers approved the agreement, according to the New York Times. The headline number, per CNBC: $16.7 billion.

But just how much they’ll pay is debatable: The attorneys general touted $17.1 billion, which folds in roughly $459 million tied to the separate Cambridge Analytica matter. Meta puts the total closer to $18 billion, including a separate $1 billion settlement with Texas, BBC reports. The money will be paid in annual installments over 10 years and, of course, Meta denied any wrongdoing.

About 70% goes to the 47 participating states. The remaining 30% is contingent—it only lands if YouTube and TikTok adopt similar changes and match the payments. Think of it as a bounty on the rest of the industry. CBS News pegs that contingent pot at around $5 billion.

The product changes are the real story. Facebook and Instagram get a default two-hour daily limit for teens, overnight blocks, muted notifications during school hours, hidden likes, age-verification measures and an option to turn off the algorithmic feed entirely.

School-district and personal-injury suits against Meta are still live, so the legal bill isn’t final. But what’s clear is that teens are about to get logged out at bedtime.

 
Yes, But:

Meta stock actually jumped after the settlement.
 

Judge Allows Trump’s Mail-In Ballots Plan

 

At least for now … with litigation moving quickly, the president’s proposal could still be blocked

The last nationwide block on Trump’s mail-in voting order is gone. U.S. District Judge Indira Talwani in Boston lifted her injunction Wednesday, clearing the Postal Service to apply its new rule to the November midterms. She moved after the Supreme Court vacated a related injunction Monday, 6-3, on procedural grounds. But neither decision touched whether the policy is actually legal.

The rule itself landed Aug. 21, a 95-page final version that requires states to submit every mail voter's name and address to a federal portal, along with unique barcodes. States also have to submit ballot-envelope designs for review. Mailings that don’t comply get rejected and returned.

Three challenges are still pending, including a new suit from 23 states and Washington, D.C., joined by Pennsylvania Gov. Josh Shapiro, CNBC reports. USPS had said it wouldn't apply any of this to 2026 unless both injunctions came off … and now both are off. About 30% of voters cast mail ballots in 2024, and Election Day is Nov. 3, which gives election officials in all 50 states a compressed window to rebuild their ballot pipelines around a federal portal they’ve never used.

 
Unresolved:

Talwani gave the government until noon today to respond to a request for a fresh injunction.

Partner

How I Passed 9 Apex Evals in a Single Week

When Mark Helweg traded his Apex evaluations, he didn’t rely on breaking news, complicated predictions, or a screen packed with indicators.

He followed a simple visual strategy: Buy on Blue. Sell on Red.

The signals came from the same award-winning hedge fund algorithm Mark designed to identify changes in market pressure.

Now Mark is breaking down the setup in a free report, including how he used it during nine successful Apex evaluations in one week.

 
The Break Down:
 
Get your free copy today
 

FDA Approves Pill for Deadly Cancer

 

The pancreatic cancer patients' survival rates nearly doubled

More progress in the fight against cancer: The FDA approved Rasonque on Wednesday, a once-daily pill from for adults with advanced pancreatic cancer who’ve already been through treatment. It cracks the mutated proteins that drive the disease that scientists spent decades calling “undruggable”.

In a 500-patient randomized trial, people taking the drug alone (not alongside chemo) lived a median 13.2 months, versus 6.7 months for those on chemotherapy. Roughly double. The agency cleared it more than six months ahead of its own deadline.

The only catch is the list price—$39,800 a month before insurance—and no one has said what patients actually pay, when the pill reaches pharmacies or whether insurers have committed to covering it. Researchers now want to test the same approach in lung, colorectal and other cancers. Which is the bigger story, eventually.

 
FYI:

The pancreas is a small gland behind your stomach. It makes juices that help digest food and hormones like insulin that control blood sugar.

Have you
heard about ...

 
 
 
 
 
 

🔒

Today’s Member Extras

Valet. Member

Exclusive

 

Culture Debriefing

The Trends You Need to Know About Right Now

 

Dolly Parton’s Manager Details the Business Ventures ‘She Had Yet to Fulfill’

 

Today on

 

From a pair of waterproof trail sneakers to an unexpected golf collab, these are the kicks our team can’t stop talking about.

 
 

The pieces everyone loves, for less.

 

Morning Motto

Appreciate the little things.

 

Follow: @mymind